We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DOW:NYSEDow Inc. Analysis

Data as of 2026-03-11 - not real-time

$33.89

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Dow Inc. is trading well above its 20‑day, 50‑day and 200‑day moving averages (price $33.89 vs SMA20 $31.93, SMA50 $29.14, SMA200 $25.84) and the MACD line sits above its signal, indicating a short‑term bullish momentum. The RSI at 64 reinforces this upside bias while the stock remains comfortably above the identified support at $29.20, though the resistance near $35.75 looms. However, the fundamentals are fragile: revenue is down 9%, margins are negative, trailing EPS is –$3.70 and free cash flow is negative, while debt ($19.6 B) dwarfs cash ($4.3 B) and the debt‑to‑equity ratio exceeds 100. The forward PE of roughly 49 and a high dividend yield of 5.1% mask a payout ratio that appears unsustainable given the earnings shortfall. Recent analyst upgrades to Overweight/Outperform reflect confidence in the technical setup and the newly declared dividend, but price targets averaging $29–$33 suggest a potential downside from current levels.
Overall, the stock presents a classic clash of strong short‑term price dynamics against a weak underlying financial profile, elevated volatility (≈49% 30‑day) and a high beta, making it a high‑risk play that may suit momentum traders but warrants caution for longer horizons.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical indicators (price above SMAs, MACD bullish)
  • Elevated volatility and high beta increasing price swing risk
  • Unsustainable dividend given negative earnings and cash flow

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Continued earnings weakness and high leverage
  • Analyst upgrades but price targets below current level
  • Potential pressure on dividend if cash flow does not improve

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Persistent negative margins and free cash flow deficit
  • Debt load far exceeding cash reserves
  • Forward valuation (PE ~49) suggesting limited upside

Key Metrics & Analysis

Financial Health

Revenue Growth-9.10%
Profit Margin-6.56%
P/E Ratio49.1
ROE-13.82%
ROA-0.07%
Debt/Equity111.87
P/B Ratio1.5
Op. Cash Flow$1.0B
Free Cash Flow$-784750016

Technical Analysis

TrendBullish
RSI64.6
Support$29.20
Resistance$35.75
MA 20$31.93
MA 50$29.14
MA 200$25.84
MACDBullish
VolumeIncreasing
Fear & Greed Index76.91

Valuation

Target Price$33.53
Upside/Downside-1.06%
GradeOvervalued
TypeValue
Dividend Yield5.10%

Risk Assessment

Beta1.49
Volatility48.87%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.